Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

People with alopecia areata are more likely to have other immune-related conditions.

Alopecia Areata might be linked to Crohn's disease.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Regulatory T cells are essential for normal and improved wound healing in mice.

Ustekinumab helped three kids with alopecia areata regrow hair.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Hair growth phase in mice weakens certain immune responses.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

A small 3D skin model helps study how immune cells move in the skin.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

New treatments for seborrheic dermatitis show promise for difficult cases.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Dupilumab users have a higher risk of developing alopecia areata.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.